Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on …
About Us - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with …
Pipeline - RAPT Therapeutics
RAPT Therapeutics is focused on the development of therapies for patients with significant unmet needs in inflammatory and immunologic diseases. Utilizing our deep and proprietary expertise …
Science - RAPT Therapeutics
RPT904 long-acting anti-IgE antibody RPT904 is a novel half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobulin E (IgE), a key driver of allergic diseases. …
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 …
Dec 31, 2024 · RAPT Therapeutics, Inc. (“RAPT” or the “Company”) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and …
RAPT Therapeutics Announces $150 Million Private Placement
Dec 23, 2024 · RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing therapies for patients with significant …
RAPT Therapeutics Reports Third Quarter 2025 Financial Results …
Sep 30, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with …
Careers - RAPT Therapeutics
RAPT Therapeutics is a biotechnology company with an unrelenting determination and passionate drive to employ its expertise in immunology, drug discovery and computational sciences to …
Press Releases - RAPT Therapeutics
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies October 21 | 2025
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse …
Jun 13, 2025 · RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …